Carclo plc Directorate Change (8649R)

TIDMCAR

RNS Number : 8649R

Carclo plc

26 September 2017

26 September 2017

Carclo plc ("Carclo" or the "Company")

Board changes

The Board announces that Robert Rickman will retire from the Board at the end of December 2017, after nearly six years as Non-Executive Director and the Chairman of the Remuneration Committee. Robert has made a substantial contribution to the strategic direction of the Company and the Board thanks him for his service.

The board is also pleased to announce that Mark Rollins will be appointed to the Carclo Board as a Non-Executive Director, and the Chairman of the Remuneration Committee with effect from 1 January 2018. He is currently Senior Non-Executive Director of Tyman plc and Vitec plc and Non-Executive Chairman of Sigma Precision Components UK Limited. Previously he was Group Chief Executive of Senior plc ("Senior") from March 2008 to June 2015. He is a Chartered Accountant and joined Senior from Morgan Crucible plc as a Division Finance Director in March 1998 and was appointed Group Finance Director in July 2000.

There are no further disclosures relating to Mark Rollins required under paragraph 9.6.13R of the Listing Rules.

 
Enquiries: 
 
Carclo plc                      01924 268040 
Chris Malley, Chief Executive 
Robert Brooksbank, Finance 
 Director 
 
 
Peel Hunt LLP                   0207 418 8900 
Justin Jones 
Matthew Brooke-Hitching 
 
Weber Shandwick Financial       020 7067 0700 
Nick Oborne 
Tom Jenkins 
 

Notes to editors

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there remain significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of Group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of Group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAPGUWWBUPMGPQ

(END) Dow Jones Newswires

September 26, 2017 08:34 ET (12:34 GMT)